Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Immuquest logo — Quality Immunological Reagents Worldwide

Immuquest

Quality Immunological Reagents Worldwide

Founded 2002 United Kingdom United Kingdom 3 employees Biotechnology, Manufacturing

General Information

Company Name Immuquest
Founded Year 2002
Location United Kingdom United Kingdom
Employees 3
Industries Biotechnology, Manufacturing
Social

BounceWatch is an independent company data service, not affiliated with Immuquest. To contact Immuquest, visit immuquest.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Immuquest compare?

A PDF of Immuquest and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Immuquest soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Immuquest

Immuquest is a biotechnology startup based in United Kingdom that specializes in providing quality immunological reagents worldwide. Established in 2002, the company's mission is to collaborate with the global scientific community to offer a unique and niche range of quality antibodies tailored to both established and emerging areas of scientific interest. Immuquest operates with a customer-centric approach, directly serving research scientists across the globe. The company's commitment to delivering high-quality antibodies for scientific research reflects its dedication to meeting the evolving needs of the research community. Immuquest's focus on direct sales to scientists underscores its hands-on approach and strong customer engagement. As the company operates at the intersection of biotechnology and manufacturing, it is positioned to leverage its expertise in these industries for continued growth and innovation. Immuquest's diligent efforts to cater to the specialized requirements of the scientific community set it apart in the biotechnology and manufacturing sectors. The company’s emphasis on quality and niche offerings aligns with the evolving landscape of scientific research, presenting promising opportunities for expansion and impact. As of now, there is no publicly available information on the company's latest investment details or the involved investors. Nonetheless, Immuquest's distinctive niche, commitment to quality, and direct customer approach form a strong foundation for potential investment opportunities and continued success in the biotechnology and manufacturing sectors.

Taxonomy: monoclonal antibodies, immunological reagents, antibody design, antibody manufacture, research partnership, scientific community, quality antibodies, scientific applications, worldwide distribution

No funding data available for Immuquest yet.

Immuquest Alternatives & Competitors

View All Alternatives
Immuquest vs
Biorbyt
Biorbyt United Kingdom

Biorbyt has a simple yet challenging mission: to provide the best service to the global scientific c...

13 employees
Biotechnology, Health Care
Immuquest vs
CEDARLANE
CEDARLANE Canada

Canada's Most Trusted Source for Science

61 employees
Biotechnology, Manufacturing
Immuquest vs
Bethyl Laboratories, Inc. | Fortis Life Sciences
Bethyl Laboratories, Inc. | Fortis Life Sciences United States

Bethyl is now a part of Fortis Life Sciences.

39 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Immuquest

Quality Immunological Reagents Worldwide
Immuquest was founded in 2002.
Immuquest is headquartered in United Kingdom.
Immuquest operates in Biotechnology and Manufacturing. Its work centres on monoclonal antibodies, immunological reagents, antibody design and antibody manufacture.
Immuquest has approximately 3 employees.
Top alternatives and competitors to Immuquest include Biorbyt, CEDARLANE, Bethyl Laboratories, Inc. | Fortis Life Sciences, Aqua-Science LLC, Reagents. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Immuquest and Biorbyt are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Immuquest, https://bouncewatch.com/company/immuquest, updated 29 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes